If you have been reading about dihexa and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-02-26. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide whose structure is modeled on angiotensin IV. Its chemical name often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, though vendor and publication naming can differ. The molecule combines a short amino acid sequence with a hexanoic acid group and an amide terminus. It is classed as a small research peptide rather than a conventional drug. Databases may list it under several synonyms, so matching names are important when comparing sources.
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
| Property | Value | Notes |
|---|---|---|
| Primary reported target | Hepatocyte growth factor/c-Met signaling | Findings mainly from cell and animal studies. |
| Related endogenous peptide | Angiotensin IV | Dihexa is described as a stabilized analog. |
| Common analytical method | Reverse-phase high-performance liquid chromatography | Used for purity assessment. |
| Identity confirmation | Mass spectrometry | Provides a molecular mass check. |
| Regulatory status | Not approved for human use | Sold as a research chemical in many jurisdictions. |
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Caspase-3 is a crucial executioner protease in the apoptotic pathway, responsible for orchestrating the dismantling of cellular components during programmed cell death. Synthesized as an inactive zymogen, caspase-3 is activated by upstream initiator caspases-such as caspase-8 and caspase-9 through proteolytic cleavage, which exposes its active site and enables it to cleave a broad range of cellular substrates, including structural proteins, cell cycle regulators, and DNA repair enzymes. This proteolytic activity leads to hallmark features of apoptosis, such as chromatin condensation, DNA fragmentation, and the formation of apoptotic bodies, facilitating the orderly removal of dying cells. Caspase-3's function is tightly regulated by post-translational modifications and interactions with other cellular proteins, ensuring that apoptosis proceeds only under appropriate physiological conditions. Its essential role is underscored by its requirement for normal development and tissue homeostasis, and dysregulation of caspase-3 activity has been implicated in various diseases, including neurodegenerative disorders and cancer. Caspase-3 has been found to be necessary for normal brain development as well as its typical role in apoptosis, where it is responsible for chromatin condensation and DNA fragmentation. Elevated levels of a fragment of Caspase-3, p17, in the bloodstream is a sign of a recent myocardial infarction. It is now being shown that caspase-3 may play a role in embryonic and hematopoietic stem cell differentiation.
Both books explored the history of grunge in detail and touch upon Alice in Chains and Staley's life and death via interviews with Staley's mother, friends and bandmates, including Cantrell, Kinney, Starr and Inez. In August 2015, journalist David de Sola released the biography Alice in Chains: The Untold Story, which is mainly focused on Staley and features interviews with his friends and relatives; the surviving members of Alice in Chains did not partake in interviews for this book. In November 2025, a hardcover book titled This Angry Pen of Mine: Recovering the Journals of Layne Staley was released featuring Staley's handwritten lyrics, personal poetry, original artwork along with rare photos and fan tributes. The book was created and published in co-operation with Staley's family.
== Tourism == The World Economic Forum's Travel & Tourism Competitiveness Index 2017 Report, ranked Thailand 34 of 136 nations (1=most competitive, 136=least competitive). Other ASEAN nations ranked were: Singapore, 6; Malaysia, 26; Indonesia, 42; Vietnam, 67; Philippines, 79; Laos, 94; Cambodia, 101. International Tourist Arrivals and Receipts: Thailand ranked number nine in 2016, with 32.5 million arrivals. It ranked third in international tourism receipts, US$49.9 billion. Global Destinations Cities Index 2016: In this seventh annual survey published by MasterCard, Bangkok ranked number one of 100 cities worldwide as the top global destination city as determined by number of visitors. It displaced London, the previous number one. Other ASEAN cities ranked in the survey were Singapore, 6; Ho Chi Minh City, 42; Hanoi, 52; Jakarta, 66; and Manila, 74. Travel and Tourism Competitiveness Report 2015: Thailand ranked 35 of 141 nations. Among ASEAN nations, Singapore was ranked 11; Malaysia, 25: Indonesia, 50; Philippines, 74; Vietnam, 75; Laos, 96; Cambodia, 105; and Myanmar, 134. International Tourist Arrivals: Thailand ranked number ten in 2013, up five places from 2012 with 26.5 million arrivals. International Tourist Receipts: Ranked number seven in the world in 2013, up two places from 2012, with receipts estimated at US$42.1 billion. Total tourism contribution to GDP: Thailand ranked 18 of 184 nations in 2014, with travel and tourism income totalling 2,345 billion baht or 19.3 percent of GDP.
Deionized water is very often used as an ingredient in many cosmetics and pharmaceuticals. "Aqua" is the standard name for water in the International Nomenclature of Cosmetic Ingredients standard, which is mandatory on product labels in some countries. Because of its high relative dielectric constant (~80), deionized water is also used (for short durations, when the resistive losses are acceptable) as a high voltage dielectric in many pulsed power applications, such as the Sandia National Laboratories Z Machine. Distilled water can be used in PC water-cooling systems and Laser Marking Systems. The lack of impurity in the water means that the system stays clean and prevents a buildup of bacteria and algae. Also, the low conductance reduces the risk of electrical damage in the event of a leak. However, deionized water has been known to cause cracks in brass and copper fittings. When used as a rinse after washing cars, windows, and similar applications, purified water dries without leaving spots caused by dissolved solutes. Deionized water is used in water-fog fire-extinguishing systems used in sensitive environments, such as where high-voltage electrical and sensitive electronic equipment is used. The 'sprinkler' nozzles use much finer spray jets than other systems and operate at up 35 MPa (350 bar; 5,000 psi) of pressure. The extremely fine mist produced takes the heat out of fire rapidly, and the fine droplets of water are nonconducting (when deionized) and are less likely to damage sensitive equipment.
=== Cycloelimination reaction === This reaction occurs mainly in four-membered cyclic molecules. Once ionized, it produces a distonic ion and then further fragments to yield an ethene radical ion and a neutral ethene molecule.
Sources: en.wikipedia.org
Osemozotan (INNTooltip International Nonproprietary Name; developmental code names MKC-242 and MN-305) is a selective 5-HT1A receptor agonist with some functional selectivity, acting as a full agonist at presynaptic and a partial agonist at postsynaptic 5-HT1A receptors. 5-HT1A receptor stimulation influences the release of various neurotransmitters including serotonin, dopamine, norepinephrine, and acetylcholine. 5-HT1A receptors are inhibitory G protein-coupled receptor. Osemozotan has been shown in animal studies to have antidepressant, anxiolytic, antiobsessional, serenic, and analgesic effects. It is used to investigate the role of 5-HT1A receptors in modulating the release of dopamine and serotonin in the brain and their involvement in addiction to stimulants such as cocaine and methamphetamine.
=== October === 9 October Críostóir Ó Floinn, 95, writer. Hugh Friel, 71, drummer (The Atrix). 10 October – Dónal O'Neill, 56, Gaelic footballer (Edenderry, Offaly senior team). 13 October – Hugh Russell, 63, boxer, Olympic bronze medallist (1980). 15 October – Gerry Ryan, 68, footballer (Bohemians, Derby County, Brighton, national team). 17 October – Paul Reynolds, 50, cricket umpire. 29 October – Jimmy Duggan, 93, hurler (Liam Mellows, Galway senior team, Connacht). 31 October – Séamus Leydon, 81, Gaelic footballer (Dunmore MacHales, Nemo Rangers, Galway senior team, Connacht).
== Biology, medicine and chemistry == Code C08 Calcium channel blockers, in ATC (Anatomical Therapeutic Chemical Classification System) C08, Malignant neoplasm of other and unspecified major salivary glands ICD-10 code C8 complex, three proteins involved in the complement system (part of the immune system) Cervical spinal nerve 8 in human anatomy Carbon-8 (C-8 or 8C), an isotope of carbon An octyl-type hydrocarbon with eight carbon atoms like in a C8 bonded silica stationary phase column, a type of column used in reversed-phase chromatography Perfluorooctanoic acid (PFOA, known colloquially as C8), a ubiquitous chemical used in the production of PTFE
"Precautionary measures in radiation protection use the generally accepted model that the risk of lung cancer increases uniformly (linearly) with radon concentration. This means that an increased risk of lung cancer does not only occur above a certain value, but that a guideline or limit value only adjusts the magnitude of the risk in a meaningful way to other existing risks. Achieving a guideline or limit therefore means taking a risk that is still (socially) acceptable. It therefore makes perfect sense to take simple measures to reduce radon levels, even if they are below the guideline values." In Austria, the Radon Protection Ordinance in its version of September 10, 2021 is currently in force, which also defines the radon protection areas and radon precautionary areas.
Sources: en.wikipedia.org
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.
Reverse-phase high-performance liquid chromatography is commonly used to assess purity. Mass spectrometry is used to confirm molecular identity. These methods are typical for synthetic peptides and research chemicals.
Dihexa is not approved as a drug in major jurisdictions. It is often sold as a research chemical, which is not the same as a medicine. Its legal status can vary by country and may change.
Dihexa is a synthetic peptide analog related to angiotensin IV. It is studied in preclinical research for effects on neural signaling and synapse formation. It is not an approved medicine.